What is the recommended usage and dosage of Humalog (insulin lispro) 75/25 for patients with type 1 or type 2 diabetes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Humalog 75/25 Usage and Dosing Guidelines for Diabetes

Humalog 75/25 (insulin lispro protamine/insulin lispro) should be administered twice daily, 5-15 minutes before breakfast and dinner, with typical starting doses of 0.3-0.5 units/kg/day divided between morning and evening doses for patients with type 1 or type 2 diabetes. 1, 2

Formulation and Mechanism

  • Humalog 75/25 (also known as Humalog Mix75/25 in the US) is a premixed insulin containing 75% insulin lispro protamine suspension (intermediate-acting) and 25% insulin lispro solution (rapid-acting) 3
  • This formulation provides both immediate postprandial coverage and extended glucose control between meals 3, 4

Dosing Recommendations

  • For insulin-naïve patients, start with 0.3-0.5 units/kg/day divided into two doses 5, 2
  • For patients with higher risk of hypoglycemia (elderly, renal impairment, poor oral intake), use lower starting doses 5, 2
  • For patients already on insulin therapy, maintain the same total daily dose initially when switching to Humalog 75/25, but adjust the distribution to approximately 2/3 before breakfast and 1/3 before dinner 1
  • Administer 5-15 minutes before meals, though studies show it can be given immediately after meals with similar efficacy in elderly patients 6

Clinical Evidence

  • Humalog 75/25 provides better postprandial glucose control compared to human insulin 30/70 mixtures, with significantly lower 2-hour postprandial glucose excursions 3, 4
  • In patients with type 2 diabetes, Humalog 75/25 improved 24-hour plasma glucose profiles compared to human insulin 30/70 4
  • When administered three times daily (before each main meal), premixed insulin analogs like Humalog Mix50 showed better glycemic control than twice-daily human insulin 30/70 7

Monitoring and Adjustment

  • During initiation or transition to Humalog 75/25, more frequent blood glucose monitoring is essential, particularly focusing on both fasting and postprandial glucose levels 1, 2
  • Adjust doses based on:
    • Fasting blood glucose for morning dose
    • Pre-dinner and bedtime glucose for evening dose 2
  • Target fasting glucose values should be within the normal range according to individualized goals 1
  • If hypoglycemia occurs, reduce the dose by 10-20% 1

Comparison to Other Regimens

  • Basal-bolus insulin regimens provide more flexibility but require more injections than premixed formulations 5
  • For patients with type 2 diabetes who fail to achieve glycemic targets on basal insulin alone, adding a premixed insulin like Humalog 75/25 can improve control 5, 2
  • Premixed insulin therapy (70/30 human insulin) has been associated with higher rates of hypoglycemia in hospitalized patients and is not recommended in the hospital setting 5

Special Considerations

  • Consistent meal timing is particularly important with premixed insulin regimens to avoid hypoglycemia 1, 8
  • Humalog 75/25 should not be mixed with other insulins in the same syringe 8
  • For patients with carbohydrate-rich breakfast meals, Humalog Mix50 (50% lispro protamine/50% lispro) before breakfast may provide better postprandial control than Humalog 75/25 9

Common Pitfalls to Avoid

  • Never mix Humalog 75/25 with other insulins, especially glargine (Lantus), in the same syringe 8
  • Avoid using premixed insulin formulations in hospitalized patients due to higher risk of hypoglycemia 5
  • Don't use the same dose for both morning and evening injections; the morning dose should typically be higher than the evening dose 1
  • Never neglect monitoring during transition periods between insulin regimens, as this is when hypoglycemia risk is highest 1, 2

References

Guideline

Insulin Regimen Conversion

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Insulin Therapy for Diabetes Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Metabolic control in patients with type 2 diabetes using Humalog Mix50 injected three times daily: crossover comparison with human insulin 30/70.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2004

Guideline

Insulin Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.